FDA: No Lou Gehrig’s disease risk with statins

An analysis of dozens of studies found the widely used statin cholesterol drugs do not increase the risk of Lou Gehrig's disease, U.S. health officials said on Monday.

Comments

• Find It

• Recently Written

  • test post
  • Possible Case: Stem Cell Therapy Web Sites
  • (Revised December 3, 2008) Health Canada Warns Consumers That The Unauthorized Natural Health Product Kwan Loong Medicated Oil May Cause Adverse Health Effects
  • Possible Case: Innohep (Tinzaparin
  • Brand-Name Drugs Do Not Appear Superior to Generic Drugs for Treating Cardiovascular Disease
  • PhRMA Statement on JAMA Study
  • Innohep (tinzaparin sodium injection)
  • Tracking Eye Disorders in Statin Users; Predicting Visual Outcomes…
  • Epilepsy Drug May Increase Risk of Autism in Children
  • Paladin Labs, GSK Sign Dexedrine Pact

• Categories

  • News

• Monthly Archives

  • December 2008
  • November 2008
  • October 2008
  • September 2008
  • August 2008
  • July 2008
  • June 2008
  • May 2008
  • April 2008
  • March 2008
  • February 2008
  • January 2008
  • December 2007
  • November 2007
  • October 2007
  • December 1969

• Blogroll

  • Attorney Daily » Drug Injury News
  • Dangerous Drug Lawyer
  • Drugs.com - Pharma News
  • FDA MedWatch
  • Health Canada RSS
  • Lawyers and Settlements :: Drugs/Medical
  • Medication News

• Admin

  • Register
  • Log in
  • XHTML

Copyright © 2008 Drug Injury News